Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114685645A details a novel Semaglutide synthesis using NCL and desulfurization, offering improved purity and cost reduction for API manufacturing.
Patent CN103304659B reveals advanced solid-phase synthesis for Liraglutide. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN112300250B details novel Anidulafungin analogs with improved solubility and reduced toxicity. Discover scalable synthesis routes for high-purity antifungal intermediates.
Advanced synthetic route for Daptomycin antibiotic using solid-liquid phase combination. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103880945A details a novel fragment condensation method for Thymalfasin, offering >99% purity and enhanced scalability for reliable pharmaceutical intermediate supply chains.
Patent CN111944037B reveals advanced solid-phase peptide synthesis reducing impurities. Enhances supply chain reliability and cost efficiency for global pharmaceutical manufacturers.
Patent CN111944037B reveals advanced fragment condensation for semaglutide. Enhances purity and yield while enabling cost reduction in API manufacturing for global supply chains.
Patent CN107778351B reveals high-purity octreotide synthesis. Achieve cost reduction in peptide manufacturing with scalable all-solid-phase methods.
Patent CN104497130A reveals a novel 2+6 segment condensation method for Lanreotide, enhancing purity and yield for cost-effective peptide manufacturing supply chains.
Patent CN103214568A details a novel Fmoc solid-phase method using pseudo-proline dipeptides to enhance yield and purity for industrial secretin production.
Patent CN112194708A details a novel Procatide synthesis using FMPB-modified resin and stepwise disulfide bonding, ensuring high purity and yield for reliable supply chains.
Patent CN119053617A reveals mixed phase synthesis for dual agonists. Enhances purity and yield for reliable pharmaceutical intermediates supplier partnerships globally.
Novel fragment condensation method for Gelpaglutide improves crude purity to over 75 percent and total yield to nearly 30 percent, offering significant cost reduction in polypeptide manufacturing.
Patent CN113748125A details a robust solid-phase method for Liraglutide and Semaglutide. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN112125970A reveals a novel solid-phase synthesis for Semaglutide using specialized Asp protection and fragment condensation to enhance yield and purity for reliable API manufacturing.
Patent CN112521482A reveals a solid-liquid combined method for nesiritide. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Patent CN112062811A details a green electrochemical method for Vilacatide. Achieve high purity and cost reduction in peptide API manufacturing with scalable solid-phase technology.
Novel solid-phase synthesis method for Omega-Conotoxin GVIA. Enhances disulfide bond accuracy and yield for pharmaceutical intermediates supply chain.
Patent CN102875665A reveals a high-yield fragment condensation method for Liraglutide, offering superior purity and cost-effective manufacturing alternatives to recombinant technologies.
Patent CN103864918A reveals efficient fragment condensation for liraglutide. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.